Patent · US Active

Method of treatment for reducing pulmonary inflammation in a patient with pathogen infection using oral prostacyclin analog drugs

US11065260B1 · kind B1 · utility

0Cited by

2References

2Claims

0Family size

Inventors

Alan C. Nelson · Redmond, US
Daniel J. Sussman · Auburn, US

Key dates

Filing date	Apr 13, 2020
Grant date	Jul 20, 2021
Priority date	—
Expiry date	Apr 13, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of reducing mortality in a human patient with pulmonary inflammation due to coronavirus or other pathogen, the method including administering an oral dose of a prostacyclin analog drug to the patient within a therapeutic window. The prostacyclin analog drug includes oral iloprost or iloprost betadex clathrate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.